AMD Treatments That Are Under Trials and Research

Besides FDA-approved AMD treatments, thereRadiation treatment such as X-rays is also used
are still many investigational treatments that areto deal with AMD, which is still under early clinical
under trial. These treatments are provided only ifstudies.
the patient acts as a volunteer to test theirAMD can be treated in another particular way.
safety and effectiveness.Since AMD is associated with slow blood flow and
While Avastin has been used to treat colorectalcapillary vessel damage caused by macro-proteins
cancer, it has not been approved to treat macularand fatty components, procedures that can
degeneration. Some ECPs only use Avastin in theremove these harmful substances are effective.
form of off label. Studies show that AvastinOne of such procedures is the RHED procedure,
brings positive results in AMD treatment. Likewhich is also under trials.
these FDA-approved treatments such as LucentisInjected into a vein in the arm, the ICG dye is
and Macugen, Avastin also function by injectionused to detect the presence and location of
into the eye.neovascular vessels. The Feeder Vessel Therapy
Another treatment aiming at stopping thealso uses a high speed camera to trace the dye
abnormal blood vessel growth is named Vascularduring its progression into the abnormal vessels.
Endothelial Growth Factor (VEGF) Trap-Eye. ThisAMD patients always have central blind spots, so
treatment was reported to be as effective asthat doctors have invented a tiny, implanted
Lucentis for wet AMD.device to magnify images onto the retina. This
Retaane treats advanced macular degenerationtreatment is known as implantable telescope,
by attacking enzymes, which allows abnormalwhich has received significant clinical trial results.
blood vessel growth. Left untreated, enzymes willAnother potential AMD treatment is Transpupillary
weaken the walls of retinal blood vessels. RetaaneThermotherapy, which combines an infrared laser
performs in a way that is quite different fromand drug treatment. While its creator announces
most of those AMD treatments. It is depositedpositive effects, some patients say it is
behind the eye alongside the sclera and will bedissatisfying.
replaced every six months.Other researches focus on both artificial retinas
By preventing abnormal blood vesseland gene therapy, which are in early stages.
development, Combretastatin is indicated to slowArtificial retina can permanently recover the vision
or halt myopia AMD progression, which affectsof AMD patients. Gene therapy is conceived to
young people with some eye diseases. Theintroduce specially encoded genes to alter AMD
company is still carrying out clinical studies toprocess.
demonstrate that whether the treatment isFor patients failed to get satisfied with all those
effective for AMD on old people.moderate treatments. They can finally resort to
Encapsulated Cell Technology (ECT) is designed toan AMD surgery, which can remove the damaged
maintain sustained release of geneticallytissues.
engineered cells, in order to reduce retinal damage.